Molecular Vision
Latest round
- Seed
Last raised
- Aug 2007
Total raised
- $0.7M
Investors
- 1
About Molecular Vision
Molecular Vision is a biotechnology company specializing in advanced diagnostic tools and molecular assays designed for healthcare professionals.Founded in 2001, Molecular Vision is based in London, UK. The company specializes in the development of innovative biotechnology solutions. Notably, in March 2012, Abingdon Health, a portfolio company of Imperial Innovations, acquired a controlling stake in Molecular Vision.Molecular Vision specializes in innovative solutions within the biotechnology sector, focusing on products that cater to the needs of healthcare professionals and institutions. The company's core offerings primarily include advanced diagnostic tools and molecular assays that enable precise detection of various health conditions. These products are designed to streamline laboratory processes, enhance accuracy in diagnostics, and provide actionable insights for better patient management. The end users of these services primarily include hospitals, diagnostic laboratories, and research institutions that require reliable testing solutions.Molecular Vision generates revenue through a structured transactional model that includes direct sales to healthcare institutions, partnerships with diagnostic labs, and B2B collaborations with distributors. The company typically engages in long-term agreements with its clients, which may involve subscription-based services for continuous product support and updates. For the year 2021, the company reported revenues of EUR 0 mn.Molecular Vision aims to expand its product line by launching new diagnostic tools and assays by 2023 to meet the evolving needs of healthcare professionals. The company plans to penetrate new markets in Asia and North America within the next three years.50 mn will be utilized to support product development and market expansion initiatives. Additionally, in March 2012, the acquisition by Abingdon Health has positioned Molecular Vision for strategic growth opportunities within the biotech sector.
Who invested in Molecular Vision
1 investor across 1 round
See all investors in Molecular Vision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 31, 2007
Amount
$0.7M
Investors
Questions about Molecular Vision
Who invested in Molecular Vision?
Molecular Vision has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Molecular Vision raised?
Molecular Vision has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Molecular Vision last raise money?
Molecular Vision's most recent round on record is a Seed, in Aug 2007.
What does Molecular Vision do?
Molecular Vision is a biotechnology company specializing in advanced diagnostic tools and molecular assays designed for healthcare professionals.
Where is Molecular Vision headquartered?
Molecular Vision is headquartered in London, UK.
Which VCs invest in companies like Molecular Vision?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Molecular Vision's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Molecular Vision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.